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Abstract  
Colon cancer is considered to be the third most common cancer worldwide. At diagnosis of colon 
cancer, 3.7-11% developed bone metastasis. Diet based strategies are important for prevention and 
treatment of colon cancer. This study investigated the effect of vitamin B17 on a DMH induced rat 
model of colon cancer. Eighty young adult male albino rats were divided into five groups. Group I 
(control group), Group II (vitamin B17), Group III (CC), Group IV (protected) and Group V 
(treated). Distal colon sections were prepared for light and scanning electron microscopic 
examination. Lumbar vertebrae specimens were prepared for light microscopic study. 
Morphometric and statistical analysis were done. In comparison with the control, both CC and 
treated groups showed invasion of the colonic tissue by pleomorphic branching colonic glands of 
variable shapes and sizes lined with dysplastic elongated hyperchromatic nuclei with frequent 
mitotic figures or stratified multilayered crowded nuclei with an extremely significant (p˂0.0001) 
reduction of goblet cell number when compared to the control together with major pathological 
bone changes were observed in cc and the treated groups. While the protected group showed 
impressive improvement of all previously mentioned diameters. 
Key words: colon cancer rat, vitamin B17 
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INTRODUCTION  
Colon cancer is often found in patients aged 50 years or older. However, recent interest in 
Egyptian colon cancer has been raised when epidemiological studies revealed a high incidence of 
this disease among young Egyptian population aged between 30-35 years [14]. The etiology of 
colon cancer is multifactorial, including genetic, environmental and dietary factors [2]. At diagnosis 
of colon cancer, 3.7-11% developed bone metastasis [12]. Animal models are good ways to study 
the disease development. In addition, these models allow for studying the prevention of colon 
cancer [7]. Currently experimental models use 1, 2-dimethylhydrazine (DMH) which is a potent 
colon carcinogen and the most widely used colon cancer inducer. DMH causes oxidative stress by 
methylating the molecules of colonic epithelial cells [5]. Colon cancer is considered to be a 
preventable disease [25]. 
Vitamin B17, commonly known as Laetrile or Amygdalin, is claimed to be a potential 
natural chemotherapeutic agent found particularly in the seeds of common fruits such as apricots, 
peaches and apples [9]. The anti-neoplastic effect of vitamin B17 is attributed to its ability to induce 
apoptosis in tumor cells. It is also claimed to reduce the mitotic activity of these cells [18]. It would 
be therefore worthwhile to experimentally induce a rat model of colon cancer and study the possible 
role of vitamin B17 whether protective or curative.  
 
MATERIALS AND METHODS 
1, 2 Dimethylhydrazine dihydrochloride (DMH): A product of Sigma-Aldrich (Munich, 
Germany), was available in the form of white powder. It was dissolved in 1mM EDTA-Normal 
saline. It was given to the rat by intra-peritoneal injection (I.P) at a dose of 20 mg/kg/body weight 
once weekly for five consecutive weeks [23]. 
Vitamin B17: it was obtained online from (IHerb, California) in the form of capsules. The 
container served 100 capsules, each capsule served 100 mg Apricot seed extract (Vitamin B17) 
(Amygdalin). It was given at a dose of 300 mg/kg bodyweight daily by oral tube [24].   
Eighty young adult male albino rats, weighing between 160-180 gm. were obtained from 
Theodor Bilharz institute’s animal house, El-Warraq, Giza, Egypt. They were fed standard diet. 
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Ethical approval was obtained from the animal house of Theodor Bilharz Institute. Animals were 
divided into five main groups:   
— Group I (Control Group): This group consisted of 10 male albino rats; they were subdivided 
into Subgroup Ia: consisted of 5 rats; they were kept without any treatment until the end of 
the study. Subgroup Ib: consisted of 5 rats, they received 1mM EDTA intra-peritoneal once 
weekly until the end of the study. 
— Group II (Vitamin B17 group): consisted of 10 rats, they received the calculated dose of 
vitamin B17 orally daily for five weeks. 
— Group III (colon cancer (CC) induced group): consisted of 20 rats, received the calculated 
dose of DMH I.P once weekly for five weeks. 
— Group IV (Protected group): consisted of 20 rats; received first the calculated dose of 
vitamin B17 orally daily for 5 weeks then colon cancer was induced for the following 5 
weeks. 
— Group V (Treated Group): consisted of 20 rats; colon cancer was induced first with DMH 
injection by the dose mentioned above for 5 weeks, and then received the calculated dose of 
vitamin B17 for 5 consecutive weeks. 
All rats were then sacrificed after 10 weeks. 
 
Clinical assessment 
Initial and final weights were recorded [11], blood samples were taken for assessment of 
CEA levels [12]. 
 
Light microscopic study 
A small piece of the distal colon and lumbar vertebrae (cleaned of all soft tissue) were fixed 
for 24 hours in 10% neutral buffered formalin then dehydrated in ascending grades of alcohol, 
cleared and embedded in paraffin. After deparaffinizing, the 3-5 microns thick tissue sections were 
cut by microtome and were subjected to: Hx&E staining for routine histological examination, 
masson trichome staining (for colon sections) for detection of collagen fiber deposition, toluidine 
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blue (for bone sections) for assessment of bone mineralization and immunohistochemical stains for 
colon sections (ki-67 (marker of proliferation and detecting the mitotic activity), Cytokeratin 20 
(CK20 for detecting adenocarcinoma arising from epithelia that normally contain this protein), 
vascular endothelial growth factor (VEGF for detecting angiogenesis), and Caudal Type Homeobox 
2 (CDx2 protein involved in the proliferation and differentiation of intestinal epithelial cells via 
regulation of intestine-specific gene transcription with a tumor suppressor role).  
 
Scanning electron microscopic study [14] 
Samples from distal colon were subjected to post-fixation in 2% osmium tetroxide for two 
hours. They were then washed in distilled water for five minutes and passed through a series of 
graded acetones to achieve dehydration. Critical point drying was carried out with liquid carbon 
dioxide. The specimens were mounted on aluminum slabs using silver conductive paint and gold 
palladium sputter coating was achieved using a Polaron E5100 sputter coating instrument. The 
biopsies were examined by a scanning electron microscope (JEOL JSM35) at an acceleration 
voltage of 20 kV at EM unit at Faculty of medicine, Tanta University. 
 
Morphometric study 
 H&E stain (colon sections): Goblet cells number & Mitotic index, H&E stain (bone sections): 
number of bone resorption pits, masson trichome stain: percentage of surface area of collagen fiber 
deposition, toluidine blue stain: color intensity & immune-stains: percentage of ki-67 immuno-
positive nuclei, percentage of Ck20 immuno-positive nuclei, area percentage of VEGF & 
percentage of surface area of CDX2 positive immune-staining in all groups By using image 
analyzer software (Image J analyzer version 1.43o8, National Institutes of Health, USA and 
Digimizer version 4.3.5, MedCalc software). This was done in Anatomy and Embryology 
Department, Menoufia University. 
 
Statistical analysis [15] 
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Statistical Analysis was performed for the initial and final weights, CEA and for the morphometric 
results. Results were collected, tabulated and statistically analyzed by statistical package for social 
science (SPSS) version 20 on IBM compatible computer. Results were expressed as mean (X̅) ± 
standard deviation (SD). Student t-test (a test for significance comparing two groups) was 
performed. A value of p ˂ 0.05 was considered significant. 10 rats were used for each. 
 
RESULTS 
General results 
Both CC induced group and the treated group showed decreased physical activity when 
compared to the control group. 20 and 30% mortality was recorded for the CC induced group and 
the treated group respectively. 
Body weight 
Histogram 1 shows the body weight changes among the studied groups. Both CC induced 
group and the treated group showed significant (p < 0.001) decrease in their final body weight when 
compared to their initial ones. The protected group showed a non-significant decrease (p > 0.05) in 
their final weight when compared to their initial one.  
 
Biochemical results 
Histogram 2 shows the carcino-embryonic antigen (CEA) level among the studied groups. 
Compared to the control group, animals of the CC induced group showed a statistically significant 
increase (p <0.001) in their CEA level. The protected group showed a non-significant increase (p > 
0.05) in its level. The treated one showed a significant increase (p < 0.001) in the serum CEA 
concentration. 
 
Histological results 
All sections of both control and vitamin B17 groups showed nearly similar histological 
features with no statistically significant differences between them. 
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Light microscopic study 
H&E stain 
Colon sections: The colonic tissue of control group consisted of:  the innermost layer is the 
mucosa, underneath this is the submucosa, followed by the muscularis propria and finally, the 
outermost layer - the adventitia. The structure of these layers varies, in different regions of the 
digestive system, depending on their function. The mucosa showed parallel straight crypts (colonic 
glands or acini) extending to the muscularis mucosa and separated by the lamina propria. The lining 
epithelium was composed of principle simple columnar epithelial cells with oval vesicular nuclei 
and mucous secreting goblet flask shaped cells with basal dense nuclei. CC induced group (Group 
III) showed disrupted mucosal continuity with abnormal sloughing and extrusion of the necrotic 
debris into the colonic lumen, invasion of the colonic tissue by pleomorphic branching colonic 
glands of variable shapes and sizes. The abnormal glands were lined with dysplastic elongated 
hyperchromatic nuclei with an extremely significant (p ˂ 0.0001) increase in the number of mitotic 
figures or stratified multilayered crowded nuclei with an extremely significant (p ˂ 0.0001) 
reduction of goblet cell number when compared to the control. Group IV showed preservation of 
the normal colonic architecture of the mucosa which appeared with preserved continuity. Most of 
the lining epithelial cells appeared with oval vesicular euchromatic nuclei; however, few lining 
epithelial cells showed mild to moderate dysplasia with elongated hyperchromatic nuclei. Some 
disruption of the muscularis mucosa with congested blood vessels in the sub-mucosa was evident. 
This group showed an extremely significant (p ˂ 0.0001) decrease in the mitotic index and an 
extremely significant increase (p ˂ 0.0001) in the goblet cell percentage when compared to the cc 
group. Group V showed more or less distorted colonic architecture with extensive sloughing of the 
abnormal mucosa into the lumen. The lining epithelial cells showed elongated hyperchromatic 
nuclei and a non-significant decrease in number of mitotic figures when compared to cc group. An 
extremely significant (p ˂ 0.0001) reduction of goblet cell number was clearly evident. The 
muscularis mucosa layer was disrupted and the submucosa showed congested dilated blood vessel 
(Fig. 1, 2, Histogram 3, 4). 
Lumbar vertebra sections: The bone tissue control group showed regular well-organized 
parallel arrangement of the bone lamellae. The osteocytes within the bone matrix were resident 
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inside their lacunae. The bone marrow space was filled of hematopoietic cells and scattered 
adipocytes. CC induced group showed an extremely significant increase (p ˂ 0.0001) in bone 
resorption pits in the vicinity of multi-nucleated osteoclasts. The osteocytes appeared with wide 
lacunae. The bone lamellae lost their parallel well-organized arrangement with areas of sub-
periosteal bone necrosis. The bone marrow spaces were widened and invaded by tumor cell nests 
with signet ring cells. The protected group revealed more or less preserved parallel arrangement of 
bone lamellae with an extremely significant decrease (p ˂ 0.0001) in number of bone resorption pits 
compared to the cc group, together with presence of several multi-nucleated osteoclasts. The treated 
group showed tumor cell nests invading the bone marrow space and surrounding the destructed 
trabecular bone that showed a non-significant decrease (p > 0.05) of bone resorption pits number 
compared to cc group, with multi-nucleated osteoclasts (Fig. 3, Histogram 5). 
 
Special stains 
Masson Trichome stain: Comparing with the control group, cc induced group showed an 
extremely significant increase (p ˂ 0.0001) in the surface area percentage of collagen fiber 
deposition. The protected group showed an extremely significant decrease (p ˂ 0.0001) in the same 
percentage when compared to the cc group. When compared to the cc group, the treated group 
showed no statistically significant difference (p > 0.05) of the same percentage. When compared to 
the protected group, the treated group showed an extremely significant increase (p ˂ 0.0001) in this 
percentage (Fig. 4). 
Toluidine Blue stain: Comparing with the control group, CC group showed an extremely 
significant decrease (p ˂ 0.0001) in the toluidine blue color intensity. The Protected group showed a 
very significant increase (p < 0.001) in the same percentage when compared to the colon cancer 
induced group. The treated group showed a non-significant decrease (p > 0.05) in toluidine blue 
color intensity when compared to the cc group, while showed an extremely significant decrease (p ˂ 
0.0001) in toluidine blue color intensity when compared to the protected group (Fig. 5). 
Immuno-stains: Control group showed negative immune-staining for Ki-67, VEGF, mild 
positive immune-staining for Ck20 and marked positive immune-staining for CDx2. CC group 
showed strong positive immune-staining for Ki-67, VEGF and Ck20, while showed negative 
immune-staining for CDx2. The protected group showed mild to moderate positive reactions for all 
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immune-stains. The treated group showed marked positive immune-reaction for Ki-67, VEGF & 
Ck20, while showed negative reaction to CDx2 (Fig. 6, Histogram 6). 
 
Scanning Electron microscopic study: 
The control group revealed that the colonic surface mucosa was composed of rounded to 
oval well-arranged cryptal units. Each unit was covered with concentrically arranged epithelial cells 
with a central rounded lumen. The crypts were well-delineated by furrows. The cryptal units were 
loaded with mucous secretion. The cc group showed total loss of the epithelial cells covering the 
crypts. Moreover, necrotic areas of the surface mucosa were clearly evident. The surface mucosa 
was depleted of mucous secretion. The protected group showed more or less normal crypt units 
bathed with mucous secretion with preserved both covering epithelium and central lumen. 
However, some sections showed few abnormal crypts which lost their covering epithelium. The 
cryptal units of the treated group showed loss of their covering epithelium, others showed 
obliteration of the central lumen. Necrotic areas of the surface mucosa were clearly evident (Fig. 7). 
 
DISCUSSION 
With the increasing incidence of colon cancer worldwide with its very high morbidity and 
mortality rates and poor prognosis, several attempts were done to convert it to a preventable disease 
[11][5]. Vitamin B17 (Amygdalin), as a natural substance, may have anti-inflammatory and anti-
cancerous effects. The role of Vitamin B17 in treating colon cancer is still a matter of controversy. 
In this study, the elevated serum CEA levels of the colon cancer induced group judged the 
occurrence of colon cancer which was further supported by the highly significant reduction in the 
final body weight of this group when compared to the initial one. Furthermore, colon cancer was 
evidenced by the major pathological lesions affecting the colon; this was in accordance with 
Moharib et al [15].  In the current work, the earliest hallmark for colon cancer was the presence of 
hyperplastic aberrant crypt foci which are abnormal crypts diverging from the normal shape. This 
was in agreement with Youssef et al. [28]. Hyperplasia of the crypts was further evidenced in this 
study by the scanning electron microscopic results that showed hyperplastic elevated crypts' 
epithelial covering. This was supported by Paulsen et al. [20]. Sanganna and Kulkarni, [21] stated 
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that hyperplasia might be due to the oxidative stress involved in the process of tumor development. 
This mechanism might explain the highly significant increase in the mitotic index of this group 
when compared to control as shown in our results. Furthermore, in the present work, the colon 
cancer induced group showed intense positive immunoreaction for Ki-67 which might prove the 
enhanced proliferative activity. All degrees of dysplasia have been reached; mild, moderate and 
severe dysplasia with finally the anaplasia or the carcinoma stage. This was in agreement with Jucaa 
et al. [11] who used the same methodology for completion of experimental carcinogenesis by DMH. 
Colon cancer group in this study showed strong positive immune-reaction for Ck20; which 
emphasized reaching the adenocarcinoma stage; this was in accordance with Nabil et al. [16]. In the 
present study, colon cancer induced group showed a highly significant decrease in the number of 
Goblet cells or their complete absence. This was further evidenced by our SEM study which 
revealed absence of the mucous secretion in this group. In this study, colon cancer group showed a 
highly significant increase of the percentage of collagen fiber deposition. Fibrosis might suggest the 
presence of chronic inflammation, thus chronic exposure of fibroblasts to inflammatory mediators 
may drive their transition to activated myofibroblasts with consequent abnormal collagen 
production. Colon cancer induced group showed highly significant decrease in the percentage of 
CDX2 positively stained surface area; this was in agreement with Sangeetha and Nalini, [22]. In the 
current study, angiogenesis (formation of new capillaries from pre - existing blood vessels) as one 
of the most leading factors to develop bone metastasis has been proved as colon cancer group 
showed strong positive expression of VEGF. Lumbar spine was the site of choice to assess the 
possibility of bone metastasis. This was in accordance with Jimi et al., [10] who postulated that the 
lumbar spine, followed by the pelvis were the most common sites of bone metastasis in colon 
cancer (62.16%-55.40% respectively). Cassar et al., [3] attributed vertebral metastasis from colon 
cancer to a vertebral venous plexus named Baston's plexus which was considered to be the main 
source of spreading. In the present study, bone metastasis was evident due to presence of multiple 
osteolytic lesions and resorption pits. Increased activity of the osteoclasts revealed the presence of 
osteolytic type of bone metastasis. This was in accordance with Macedo et al. [13]. The presence of 
tumor cell nests inside the bone marrow cavity emphasized the metastasis. These results were in 
line with Vatandoust et al., [27] who reported that signet ring cell stage of colon cancer had a high 
rate of bone osteolytic metastasis. In the current work, when compared to the cc group, the 
protected group showed nearly normal physical activity, average food intake, a non-significant 
difference between their final body weight and their initial one. No deaths occurred among this 
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group, marvelous regenerative changes proved by the significant improvement in serum CEA level 
and the Impressive improvement of the disrupted histology that appeared very close to reach the 
normal appearance. On the contrary, the treated group did not show any impressive improvement 
compared with colon cancer induced and protected groups. The present study showed significant 
decrease in collagen fiber deposition of the protected group when compared to the treated one. This 
might suggest the anti-fibrotic action of vitamin B17. This could be explained as vitamin B17 
caused regression of inflammation with subsequent regressed fibrosis. This was in accordance with 
Bottinger and Bitzer, [1] who reported that vitamin B17 might enhance serum butyrate 
concentration which caused suppression of pro-fibrotic cytokine transforming growth factor beta 1 
(TGF-β1). Moreover, Guo et al. [8] studied the effect of amygdalin in suppressing kidney fibroblast 
proliferation and TGF-β1 secretion in the lymphocytes and thus was able to significantly postpone 
the process of renal interstitial fibrosis, which further proved the anti-fibrotic effect of amygdalin. 
Furthermore, they hypothesized that the mechanisms which might be involved include increasing 
the secretion of type I collagenase, inhibiting kidney fibroblast proliferation, accelerating apoptosis 
and suppressing type I collagen synthesis. In the present study, the protected group showed mild 
positive immunoreaction for Ki-67 which might prove the inhibition of proliferative activity. This 
finding was in agreement with Park et al., [19]. The mechanisms of vitamin B17 in defeating cancer 
cells were uncertain; however, Cassiem and De-Kock, [4] performed a very recent study on vitamin 
B17's anti-cancer role. Being selective for destructing cancer cells which lack rhodanese enzyme, 
vitamin B17 exerts its anti-oxidant action. Normal cells do have the rhodanese enzyme which 
neutralizes vitamin B17 converting it to a harmless compound; thiocyanate. Meanwhile, cancer 
cells lack rhodanese enzyme, so cyanide radical is liberated.  Moreover, Song and Xu, [24] added 
that Amygdalin could significantly increase polyhydroxyalkanoates (PHA) that induced human 
peripheral blood T lymphocyte proliferation with secretion of IL-2 and IFN-γ, and then inhibiting 
the secretion of TGF-β1, therefore enhancing the immune function.  In the current work, treatment 
of colon cancer with vitamin B17 did not either induce improvement or reversal of the pathological 
changes that occurred. This might be due to the progressive and irreversible uncontrolled 
progressive cancer cell division and bone metastasis. Ki-67, Ck20 and VEGF all showed intense 
positive immunostaining when compared to the control group. 
 
CONCLUSIONS 
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Our findings revealed that daily intake of vitamin B17 may play an important role as a 
chemo-preventive, anti-cancer, anti-inflammatory, anti-fibrotic and anti-oxidant agent. 
Furthermore; this study proved the uselessness of vitamin B17 in curing colon cancer. 
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Figure 1. A photomicrograph of colon section in all experimental groups (H&E x40). A. Control 
group: Mucosa (M) with parallel colonic crypts (encircled), submucosa (Sm) and musculosa (Ms). 
B, C. CC induced group: disrupted mucosal continuity (curved arrows) with abnormal sloughed 
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tissue extruded into the lumen (thin arrow). C- Severely distorted colonic architecture with 
complete morphological loss of the mucosa and submucosa (arrows). Necrotic debris filling the 
colonic lumen (N). D. Protected group: preservation of normal mucosal continuity (M). The 
submucosa (Sm) and musculosa (Ms) layers appear more or less normal. E. Treated group: more or 
less some distorted architecture. The mucosa and sub- mucosa are infiltrated by irregular crowded 
colonic glands (astrisks). Sloughing of the crypts into the colonic lumen (encircled). 
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Figure 2. A photomicrograph of colon section in all groups (H&E x400). A. Control group: normal 
parallel colonic glands lined by simple columnar epithelial cells with oval vesicular nucleus 
(arrows) and mucous secreting goblet cells (G) with basal flat nuclei. Lamina propria (LP). 
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Muscularis mucosa (bracket). Submucosa (Sm). B, C, D. CC group: the atypical crypts lined with 
epithelial cells with elongated crowded hyperchromatic nuclei (arrows). C. Atypical colonic glands 
(encircled) invading the muscularis mucosa layer (double headed arrows) reaching the submucosa 
(Sm). Some nuclei show frequent mitotic figures (thin arrow). D. Abnormal pleomorphic colonic 
gland (thin arrow) lined with stratified multi-layered hyperchromatic crowded nuclei invading the 
musculosa layer (asterisks). E. Protected group: the majority of the crypts appear more or less 
normal. One abnormal shape crypt (curved arrow). Disrupted muscularis mucosa layer (double 
headed arrow). Asymmetrical appearance of muscularis mucosa (brackets). Congested dilated blood 
vessel in the submucosa (asterisk). F. Treated group: Abnormal glands (encircled) invading a 
disorganized muscularis mucosa layer (double headed arrow). The lining epithelial cells possess 
either elongated hyperchromatic nuclei (curved arrows) or frequent mitotic figures (thin arrows). 
Congested dilated blood vessel in the submucosa (asterisk). 
 
 
 
Histogram 1. Mean initial and final body weight of all rats (in grams): *, **Significant increase 
 < pSignificant decrease (♦♦ ;respectively) from the initial body weight ,0.001 p < and0.05  (p<
0.001) from the initial body weight. 
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Histogram 2. Mean serum CEA concentration in all groups (ng/ml); **Significant increase from 
the control group (p ˂ 0.0001). ••Significant decrease from the colon cancer induced group (p˂ 
0.0001). ◦◦Significant increase from the protected group (p˂ 0.0001). 
 
 
Histogram 3. Mean Goblet cells percentage in all groups; **Significant decrease from the 
control group (p ˂ 0.0001). ••Significant increase from the colon cancer induced group (p˂ 0.0001). 
◦◦ Significant decrease from the protected group (p ˂ 0.0001). 
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Histogram 4. Mean mitotic index in all groups. **Significant increase from the control group (p 
˂ 0.0001). •• Significant decrease from the colon cancer induced group (p ˂ 0.0001). ◦◦Significant 
increase from the protected group (p ˂ 0.0001). 
Mitotic index = Number of mitotic figures × 100 
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Figure 3. A photomicrograph of lumbar vertebrae section in all groups (H&E x400). A. Control 
group: regular well-organized parallel arrangement of the bone lamallea (double headed arrows). 
Osteocytes inside their lacunae (thin arrows). The bone marrow spaces can be seen with large 
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vacuolated adipocytes (asterisk) and heamopoitic cells (curved arrow). B. CC group: 
multinucleated osteoclasts (thick arrows) at the site of bone scalloping (curved arrow). 
Osteocytes with wide lacunae (thin arrows). Invasion of the bone marrow spaces by tumor cell 
nest with signet ring cells (notched arrows). C. Protected group: more or less preserved 
arrangement of the bone lamellae (double headed arrows). Multi-nucleated osteoclasts (thick 
arrows). Widening of the osteocytes' lacunae (thin arrows). D. Treated group: distorted 
arrangement of the bone lamellae (double headed arrows). Tumor cell nests (encircled) invading 
destructed bone trabaculea (asterisks). Multi-nucleated osteoclast (thick arrows). Area of bone 
necrosis (N). 
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Histogram 5. Mean number of bone resorption pits; **Significant increase from the control group 
(p ˂ 0.0001). ••Significant decrease from the colon cancer induced group (p ˂ 0.0001). ◦◦Significant 
increase from the protected group (p ˂ 0.0001). 
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Figure 4. Photomicrographs of Masson Trichome stained colon sections of all groups (x400): 
A. Control group: minimal amount of collagen fiber deposition (arrows) B. CC induced group: 
large amount of collagen fiber deposition (arrows and asterisks). C. Protected group: small 
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amount of collagen deposition (thick and thin arrows). D. Treated group: large amount of 
collagen fiber deposition (arrows and asterisks). E. ** Significant increase from the control 
group (p˂0.0001) •• Significant decrease from the cc group (p˂0.0001). ◦◦Significant increase 
from the protected group (p˂0.0001). 
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Figure 5. Photomicrographs of Toluidine Blue stained lumbar vertebral sections of all groups 
(x400). A. Control group: dark blue staining of the bone sections. B. CC group: faint blue staining 
of the bone sections. C- Protected group: Average blue staining of the bone sections. D. Treated 
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group: pale blue staining of the bone sections. E. Foote notes: ** Significant decrease from the 
control group (p˂0.0001). •Significant increase from the colon cancer induced group (p˂0.05). ◦◦ 
Significant decrease from the protected group (p˂0.0001). 
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Figure 6. Photomicrographs of immuno-stained colon sections of all groups (x400): Control & 
vitamin B17 groups: negative immune-staining for Ki-67, Ck20, VEGF and positive for CDx2. 
CC induced group: strong positive immune-staining for Ki-67, Ck20, VEGF and negative for 
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CDx2. Protected group: mild to moderate immune-reaction for all immune-stains. Treated group: 
strong positive immune-staining for Ki-67, Ck20 and VEGF, but negative reaction to CDx2 
immuno-stain; S — stain; G — group. 
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Histogram 6. Mean area percentage of immune-positive nuclei (%) in all groups: **Significant 
increase (p < 0.0001) from the control group (for Ki67, Ck20 and VEGF) and Significant decrease 
(p < 0.0001) from the control group for CDx2. ••Significant decrease from the cc group for ki67, 
ck20 and VEGF and significant increase from cc group for CDx2 (p < 0.0001). ◦◦Significant 
increase from the protected group for ki67, ck20 and VEGF and significant decrease from protected 
group for CDx2 (p < 0.0001). 
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Figure 7. Scanning electronmicrographs of colon sections of all groups (SEMx 350): A. Control 
group: rounded to oval crypt units (encircled) covered with concentrically arranged epithelial cells, 
each unit is demarcated by a furrow (thick arrow) with a lumen at the center (asterisk). Mucous 
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secretion can be noticed (thin arrows). B. CC induced group: elevated crypt units with hyperplasia 
(arrows). C. CC group: crypts with narrowed slit like lumen (thick arrows), others show wide crypt 
lumen with total loss of the cells covering the crypts (thin arrows). A necrotic area can be observed 
(asterisk). D. Protected group: some crypts appear more or less normal (curved arrows), others 
show complete loss of their covering cells (thick arrow). E- Treated group: crypts with obliterated 
lumen (curved arrows), others show total loss of their covering epithelium (thick arrow). A large 
necrotic area can be noticed (asterisk). 
 
